About Us Our Focus Our Therapies
Our Pipeline Investors & News Careers

About Us

Learn about who we are, what we believe
and the people who lead us

Our Story Serving patient needs is our passion; delivering revolutionary treatments is our mission Our Leadership Our experienced leaders are bound by passion and science Our Values We live our values of commitment, empowerment and teamwork Our Responsibility Advancing a vision for change Medical Affairs We are committed to advancing science and medicine through awareness, education and research

Our Focus

Discover our unique scientific approach
for diseases with high unmet need

Demodex Blepharitis A highly prevalent and damaging eyelid disease Lyme Disease A growing public health crisis with no approved solution Ocular Rosacea A common inflammatory condition of the eyelid and eyelid margin

Our Therapies

The first and only FDA-approved
treatment for Demodex blepharitis

XDEMVY® (lotilaner ophthalmic solution) 0.25% Available to prescribe today

Our Pipeline

Explore the possibilities of our robust pipeline
to address significant unmet patient needs

Pipeline Overview A commitment to pursuing the root cause of disease TP-04 An investigational treatment for ocular rosacea TP-05 An investigational therapy for the prevention of Lyme disease

Investors & News

Find additional corporate
and stock information

Investors Overview
News & Presentations
Events
Financials
Publications Corporate Governance
Stock Information
Other Resources

About Us

Learn about who we are, what we believe
and the people who lead us

Our Story Our Leadership Our Values Our Responsibility Medical Affairs

Our Focus

Discover our unique scientific approach
for diseases with high unmet need
Demodex Blepharitis Lyme Disease Ocular Rosacea

Our Therapies

The first and only FDA-approved
treatment for Demodex blepharitis
XDEMVY® (lotilaner ophthalmic solution) 0.25%

Our Pipeline

Explore the possibilities of our robust pipeline
to address significant unmet patient needs
Pipeline Overview TP-04 TP-05

Investors & News

Find additional corporate
and stock information
Investors Overview
News & Presentations
Events
Financials
Publications Corporate Governance
Stock Information
Other Resources
Careers

Contact Tarsus

Please reach out to us using the form.

15440 Laguna Canyon Road, Ste 160

Irvine, CA 92618

(949) 418-1801

XDEMVY customer service hotline

1-888-421-4002

Tarsus EthicsPoint Helpline

1-833-224-2950

This field is for validation purposes and should be left unchanged.
Consent
*Required Fields

Our Terms of Use and Privacy Policy have changed.

By clicking accept, you agree that you have read and will abide by these new terms.

Reject Accept